REPORTS

Let’s Pullulate and Expand Your Business

Amlodipine Besylate Market - Global Professional Analysis and Forecast to 2026

Feb 06, 2020  |  159 PAGES  |  REPORT CODE: CMM265352
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Amlodipine Besylate market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period.

This report presents the market size and development trends by detailing the Amlodipine Besylate market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Amlodipine Besylate market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Amlodipine Besylate industry and will help you to build a panoramic view of the industrial development.

Amlodipine Besylate Market, By Type:

  • 2.5mg Tablets

  • 5mg Tablets

  • 10mg Tablets

Amlodipine Besylate Market, By Application:

  • High Blood Pressure

  • Heart Disease

Some of the leading players are as follows:

  • Strides Pharma

  • MACLEODS

  • Hikma Pharmaceuticals

  • Mylan

  • Cipla

  • Dr. Reddy's Laboratories

  • Wockhardt

  • CR Pharmaceutical

  • Aurobindo Pharma

  • Teva Pharmaceutical

  • Lupin Pharmaceuticals

  • Epic Pharma

  • Sun Pharmaceutical

  • Zydus Pharmaceuticals

  • InvaGen Pharmaceuticals

  • Pfizer

  • Upsher-Smith Laboratories

  • Apotex

  • Oxford Pharm

  • Alkem Laboratories

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Amlodipine Besylate Market: Technology Type Analysis

  • 4.1 Amlodipine Besylate Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Amlodipine Besylate Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 2.5mg Tablets

    • 4.3.2 5mg Tablets

    • 4.3.3 10mg Tablets

5 Amlodipine Besylate Market: Product Analysis

  • 5.1 Amlodipine Besylate Product Market Share Analysis, 2018 & 2026

  • 5.2 Amlodipine Besylate Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Amlodipine Besylate Market: Application Analysis

  • 6.1 Amlodipine Besylate Application Market Share Analysis, 2018 & 2026

  • 6.2 Amlodipine Besylate Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 High Blood Pressure

    • 6.3.2 Heart Disease

7 Amlodipine Besylate Market: Regional Analysis

  • 7.1 Amlodipine Besylate Regional Market Share Analysis, 2018 & 2026

  • 7.2 Amlodipine Besylate Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Strides Pharma

    • 9.1.1 Strides Pharma Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 MACLEODS

    • 9.2.1 MACLEODS Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Hikma Pharmaceuticals

    • 9.3.1 Hikma Pharmaceuticals Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Mylan

    • 9.4.1 Mylan Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Cipla

    • 9.5.1 Cipla Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Dr. Reddy's Laboratories

    • 9.6.1 Dr. Reddy's Laboratories Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Wockhardt

    • 9.7.1 Wockhardt Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 CR Pharmaceutical

    • 9.8.1 CR Pharmaceutical Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Aurobindo Pharma

    • 9.9.1 Aurobindo Pharma Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Teva Pharmaceutical

    • 9.10.1 Teva Pharmaceutical Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Lupin Pharmaceuticals

    • 9.11.1 Lupin Pharmaceuticals Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Epic Pharma

    • 9.12.1 Epic Pharma Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Sun Pharmaceutical

    • 9.13.1 Sun Pharmaceutical Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Zydus Pharmaceuticals

    • 9.14.1 Zydus Pharmaceuticals Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 InvaGen Pharmaceuticals

    • 9.15.1 InvaGen Pharmaceuticals Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Pfizer

    • 9.16.1 Pfizer Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Upsher-Smith Laboratories

    • 9.17.1 Upsher-Smith Laboratories Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Apotex

    • 9.18.1 Apotex Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Oxford Pharm

    • 9.19.1 Oxford Pharm Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Alkem Laboratories

    • 9.20.1 Alkem Laboratories Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

 

The List of Tables and Figures (Totals 85 Figures and 141 Tables)

  • Figure 2.5mg Tablets Amlodipine Besylate market, 2015 - 2026 (USD Million)

  • Figure 5mg Tablets Amlodipine Besylate market, 2015 - 2026 (USD Million)

  • Figure 10mg Tablets Amlodipine Besylate market, 2015 - 2026 (USD Million)

  • Figure High Blood Pressure market, 2015 - 2026 (USD Million)

  • Figure Heart Disease market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Amlodipine Besylate market, by country, 2015 - 2026 (USD Million)

  • Table North America Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table North America Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table North America Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Canada Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Canada Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Europe Amlodipine Besylate market, by country, 2015 - 2026 (USD Million)

  • Table Europe Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Europe Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Europe Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Germany Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Germany Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table France Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table France Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Italy Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Italy Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Spain Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Spain Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amlodipine Besylate market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table China Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table China Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Japan Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Japan Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table India Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table India Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Amlodipine Besylate market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table MEA Amlodipine Besylate market, by country, 2015 - 2026 (USD Million)

  • Table MEA Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table MEA Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table MEA Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Amlodipine Besylate market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Amlodipine Besylate market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Amlodipine Besylate market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Strides Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MACLEODS Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hikma Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cipla Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dr. Reddy's Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Wockhardt Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CR Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aurobindo Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lupin Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Epic Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sun Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zydus Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table InvaGen Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Upsher-Smith Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Apotex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Oxford Pharm Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alkem Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top